15: Knowledge management

door Heisig, Peter
Gepubliceerd in 2024-12-10

Pitfalls in efficacy testing – how important is the validation of neutralization of chlorhexidine digluconate?

door Reichel, Mirja, Heisig, Peter, Kampf, Günter
Gepubliceerd in 2008

Uncomplicated Urinary Tract Infections and Antibiotic Resistance—Epidemiological and Mechanistic Aspects

door Wiedemann, Bernd, Heisig, Anke, Heisig, Peter
Gepubliceerd in Antibiotics (Basel) (2014)

Modelling and management of engineering processes

door Heisig, Peter., Clarkson, P. John., Vajna, Sandor.
Gepubliceerd in 2010.

Impact of gyrA and parC Mutations on Quinolone Resistance, Doubling Time, and Supercoiling Degree of Escherichia coli

door Bagel, Simone, Hüllen, Volker, Wiedemann, Bernd, Heisig, Peter
Gepubliceerd in 1999

Alcohols for Skin Antisepsis at Clinically Relevant Skin Sites

door Reichel, Mirja, Heisig, Peter, Kohlmann, Thomas, Kampf, Günter
Gepubliceerd in 2009

In Vivo Increase in Resistance to Ciprofloxacin in Escherichia coli Associated with Deletion of the C-Terminal Part of MarR

door Linde, Hans-Jörg, Notka, Frank, Metz, Michaela, Kochanowski, Bernd, Heisig, Peter, Lehn, Norbert
Gepubliceerd in 2000

Comparative Activities of Clinafloxacin, Grepafloxacin, Levofloxacin, Moxifloxacin, Ofloxacin, Sparfloxacin, and Trovafloxacin and Nonquinolones Linozelid, Quinupristin-Dalfoprist...

door Jones, Mark E., Visser, Maarten R., Klootwijk, Miriam, Heisig, Peter, Verhoef, Jan, Schmitz, Franz-Josef
Gepubliceerd in 1999

Resistance to Moxifloxacin in Toxigenic Clostridium difficile Isolates Is Associated with Mutations in gyrA

door Ackermann, Grit, Tang, Yajarayma J., Kueper, Robert, Heisig, Peter, Rodloff, Arne C., Silva, Joseph, Cohen, Stuart H.
Gepubliceerd in 2001

A Mutation in Escherichia coli DNA Gyrase Conferring Quinolone Resistance Results in Sensitivity to Drugs Targeting Eukaryotic Topoisomerase II

door Gruger, Thomas, Nitiss, John L., Maxwell, Anthony, Zechiedrich, E. Lynn, Heisig, Peter, Seeber, Siegfried, Pommier, Yves, Strumberg, Dirk
Gepubliceerd in 2004

Prevalence of gyrA, gyrB, parC, and parE Mutations in Clinical Isolates of Streptococcus pneumoniae with Decreased Susceptibilities to Different Fluoroquinolones and Originating fr...

door Jones, Mark E., Sahm, Daniel F., Martin, Nele, Scheuring, Sibylle, Heisig, Peter, Thornsberry, Clyde, Köhrer, Karl, Schmitz, Franz-Josef
Gepubliceerd in 2000

Association of Alterations in ParC and GyrA Proteins with Resistance of Clinical Isolates of Enterococcus faecium to Nine Different Fluoroquinolones

door Brisse, Sylvain, Fluit, Ad C., Wagner, Ulrich, Heisig, Peter, Milatovic, Dana, Verhoef, Jan, Scheuring, Sybille, Köhrer, Karl, Schmitz, Franz-Josef
Gepubliceerd in 1999

In Vitro Development of Resistance to Six Quinolones in Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus

door Boos, Mechthild, Mayer, Susanne, Fischer, Ansgar, Köhrer, Karl, Scheuring, Sibylle, Heisig, Peter, Verhoef, Jan, Fluit, Ad C., Schmitz, F.-J.
Gepubliceerd in 2001

In Vitro Activities of Fluoroquinolones against the Spirochete Borrelia burgdorferi

door Kraiczy, Peter, Weigand, Judith, Wichelhaus, Thomas A., Heisig, Peter, Backes, Herbert, Schäfer, Volker, Acker, Georg, Brade, Volker, Hunfeld, Klaus-Peter
Gepubliceerd in 2001

Commonality among Fluoroquinolone-Resistant Sequence Type ST131 Extraintestinal Escherichia coli Isolates from Humans and Companion Animals in Australia

door Platell, Joanne L., Cobbold, Rowland N., Johnson, James R., Heisig, Anke, Heisig, Peter, Clabots, Connie, Kuskowski, Michael A., Trott, Darren J.
Gepubliceerd in 2011

Prominence of an O75 Clonal Group (Clonal Complex 14) among Non-ST131 Fluoroquinolone-Resistant Escherichia coli Causing Extraintestinal Infections in Humans and Dogs in Australia

door Platell, Joanne L., Trott, Darren J., Johnson, James R., Heisig, Peter, Heisig, Anke, Clabots, Connie R., Johnston, Brian, Cobbold, Rowland N.
Gepubliceerd in 2012